Genetic Technologies Ltd (GENE)
3.15
-0.02
(-0.63%)
USD |
NASDAQ |
Apr 17, 16:00
3.17
+0.02
(+0.63%)
After-Hours: 20:00
Genetic Technologies Cash from Financing (TTM): 12.17M for June 30, 2020
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (TTM) Benchmarks
Alterity Therapeutics Ltd | 33.78M |
Kazia Therapeutics Ltd | 8.600M |
Immutep Ltd | 13.70M |
Opthea Ltd | 138.48M |
Mesoblast Ltd | 74.50M |